CKD Bio Corp. 063160.KS Stock
CKD Bio Corp. Price Chart
CKD Bio Corp. 063160.KS Financial and Trading Overview
| CKD Bio Corp. stock price | 23450 KRW |
| Previous Close | 25000 KRW |
| Open | 25400 KRW |
| Bid | 24900 KRW x 0 |
| Ask | 25400 KRW x 0 |
| Day's Range | 24900 - 25400 KRW |
| 52 Week Range | 20100 - 33100 KRW |
| Volume | 4.72K KRW |
| Avg. Volume | 22.25K KRW |
| Market Cap | 138.25B KRW |
| Beta (5Y Monthly) | 1.403424 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | December 29, 2021 |
| 1y Target Est | N/A |
063160.KS Valuation Measures
| Enterprise Value | 269.26B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.9043053 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.761 |
| Enterprise Value/EBITDA | -904.04 |
Trading Information
CKD Bio Corp. Stock Price History
| Beta (5Y Monthly) | 1.403424 |
| 52-Week Change | -12.28% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 33100 KRW |
| 52 Week Low | 20100 KRW |
| 50-Day Moving Average | 26665 KRW |
| 200-Day Moving Average | 24689.25 KRW |
063160.KS Share Statistics
| Avg. Volume (3 month) | 22.25K KRW |
| Avg. Daily Volume (10-Days) | 8.17K KRW |
| Shares Outstanding | 5.49M |
| Float | 3.34M |
| Short Ratio | N/A |
| % Held by Insiders | 39.15% |
| % Held by Institutions | 0.91% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1.05:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -12.038% |
| Operating Margin (ttm) | -11.87% |
| Gross Margin | 8.56% |
| EBITDA Margin | -0.19% |
Management Effectiveness
| Return on Assets (ttm) | -3.73% |
| Return on Equity (ttm) | -12.064% |
Income Statement
| Revenue (ttm) | 152.88B KRW |
| Revenue Per Share (ttm) | 27853.04 KRW |
| Quarterly Revenue Growth (yoy) | -6.80% |
| Gross Profit (ttm) | 16.79B KRW |
| EBITDA | -297846016 KRW |
| Net Income Avi to Common (ttm) | -18403387392 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11.17B KRW |
| Total Cash Per Share (mrq) | 2036.62 KRW |
| Total Debt (mrq) | 142.19B KRW |
| Total Debt/Equity (mrq) | 98.22 KRW |
| Current Ratio (mrq) | 1.269 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8075266048 KRW |
| Levered Free Cash Flow (ttm) | -11864780800 KRW |
Profile of CKD Bio Corp.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | CKD building |
| ZIP | 03742 |
| Phone | 82 2 2194 0555 |
| Website | https://www.ckdbio.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
CKD Bio Corp. manufactures and distributes drug substances based on fermentation, synthesis, and biotechnology in South Korea. It offers drug substances in the areas of antibiotic, ß-lactamase inhibitors, immunosuppressants, anticancer drugs, obesity treatment drugs, dry eye, antivirus, antituberculosis, antihyperlipidemics, and probiotics. The company also provides contract research and development, and manufacturing services for active pharmaceutical ingredients and intermediates, and probiotics. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Q&A For CKD Bio Corp. Stock
What is a current 063160.KS stock price?
CKD Bio Corp. 063160.KS stock price today per share is 23450 KRW.
How to purchase CKD Bio Corp. stock?
You can buy 063160.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CKD Bio Corp.?
The stock symbol or ticker of CKD Bio Corp. is 063160.KS.
Which industry does the CKD Bio Corp. company belong to?
The CKD Bio Corp. industry is Drug Manufacturers-Specialty & Generic.
How many shares does CKD Bio Corp. have in circulation?
The max supply of CKD Bio Corp. shares is 5.49M.
What is CKD Bio Corp. Price to Earnings Ratio (PE Ratio)?
CKD Bio Corp. PE Ratio is now.
What was CKD Bio Corp. earnings per share over the trailing 12 months (TTM)?
CKD Bio Corp. EPS is 0 KRW over the trailing 12 months.
Which sector does the CKD Bio Corp. company belong to?
The CKD Bio Corp. sector is Healthcare.